0001179110-21-005197.txt : 20210511 0001179110-21-005197.hdr.sgml : 20210511 20210511170515 ACCESSION NUMBER: 0001179110-21-005197 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210507 FILED AS OF DATE: 20210511 DATE AS OF CHANGE: 20210511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alpern Robert J CENTRAL INDEX KEY: 0001448074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 21912317 MAIL ADDRESS: STREET 1: YALE SCHOOL OF MEDICINE STREET 2: 333 CEDAR STREET, C203 SHM CITY: NEW HAVEN STATE: CT ZIP: 06520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 edgar.xml FORM 4 - X0306 4 2021-05-07 0 0001551152 AbbVie Inc. ABBV 0001448074 Alpern Robert J 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 1 0 0 0 Common Stock, $0.01 par value 2021-05-07 4 A 0 1681 115.96 A 30121 D These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Steven L. Scrogham, attorney-in-fact for Robert J. Alpern 2021-05-11